ArticleAdvances in therapy2017

The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries.

László Gulácsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.